Omnicare (NYS: OCR) is expected to report Q3 earnings around Oct. 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Omnicare's revenues will contract -0.2% and EPS will increase 29.6%.
The average estimate for revenue is $1.54 billion. On the bottom line, the average EPS estimate is $0.70.
Last quarter, Omnicare chalked up revenue of $1.54 billion. GAAP reported sales were 1.3% lower than the prior-year quarter's $1.56 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.63. GAAP EPS were $0.17 for Q2 compared to -$0.01 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 23.9%, 230 basis points better than the prior-year quarter. Operating margin was 9.2%, 150 basis points better than the prior-year quarter. Net margin was 1.2%, 130 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.21 billion. The average EPS estimate is $2.86.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 226 members out of 246 rating the stock outperform, and 20 members rating it underperform. Among 83 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 79 give Omnicare a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omnicare is outperform, with an average price target of $37.28.
Add Omnicare to My Watchlist.
The article Omnicare Earnings Up Next originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.